Be Early. Be Insightful. Be Unique.

Venrock Healthcare Capital Partners (VHCP) adopts a venture capital like approach to investing in both micro/small-cap public and late-stage private healthcare companies that are generally illiquid, pre-revenue, and in the development-stage. We leverage our venture expertise, rigorous data analysis and long-term supportive orientation to support successful biotech companies within the public markets. This is consistent with Venrock’s rich history in venture investing across healthcare and technology, including early investments in Apple, Intel, Gilead, Illumina and Idec Pharmaceuticals.